Corona virus: Why are there doubts about the data collected for testing for COD 19 disease in Pakistan?

Image
Corona virus: Why are there doubts about the data collected for testing for COD 19 disease in Pakistan? June 24 was a difficult day for the provincial capital, Lahore, according to daily statistics from Punjab, the province most affected by coronavirus deaths in Pakistan. In those 24 hours, code-19 disease claimed 55 lives in Lahore, a record so far. In the last five days before June 24, 119 people died of the corona virus in Lahore, an estimated 24 deaths per day. But when the provincial figures for June 25 came out, it was surprising that not a single death had taken place in Lahore. The BBC contacted Mayo Hospital, the largest coronavirus hospital in Lahore, for treatment. According to hospital data, there were three confirmed and five unconfirmed deaths from Code 19 on June 24, two certified and five unconfirmed deaths on June 25, and one confirmed and three unconfirmed deaths on June 26. The reason for collecting the three-day data was to allay fears that deaths after the count de

After Russia, Turkey also succeeded in developing Japanese medicine against the corona virus

After Russia, Turkey also succeeded in developing Japanese medicine against the Corona Virus

Early trials have shown that the drug, developed in Japan for the flu, is effective in reducing the duration of disease and improving the condition of the lungs in patients with corona virus.
According to the Turkish Ministry of Health, Favipervir was obtained from China and local doctors discovered that its use helps reduce the duration of the disease, while increasing the flow of oxygen, which leads to successful and quick treatment.

To develop it locally in Turkey, the Code 19 Turkey Platform, a state-of-the-art scientific institute, worked for 40 days to specialize in the chemical synthesis of the drug.
"We have succeeded in developing this important drug with local capacity and synthesis and are now going through the licensing phase and work is underway for its immediate registration," he said.
He said that once the process is completed, the drug will be used to treat patients with corona virus in Turkey, and work will be done to export it. This Japanese drug is being tested around the world for the treatment of corona virus. Remedicators developed by Gilead Science have been found to be effective in treating the virus in various research reports, after which its emergency use in the United States and Japan has been approved.

But Russia has approved the use of the Japanese-made antiviral drug favipiravir, or in some countries, avirfavir, as a treatment for people suffering from the disease. In fact, Russia has called it a "game changer".
In April, Russia began testing the drug for cod, and initial results were encouraging. On May 13, the Russian Direct Investment Fund (RDIF) said that the results of the initial clinical trials of this drug have been excellent.

During the trial, 60 percent of coronavirus patients were treated with the drug and recovered within five days, said RDIF chief Karl Dimitrov. Time reduced by 50%. Later this month, the drug was declared safe and effective for the treatment of code 19 and it was announced that it would start treating patients in hospitals with its help from June 11. RDIF has so far discovered that the use of this drug helps to reduce the symptoms in the affected people in a very short time and also reduces the duration of high fever.

RDIF CEO Kirill Dimitrov recently said that this Japanese drug is the best in the world in terms of code 19. He described the drug as a "game changer" which he hoped would restore normalcy soon. He said that with the help of this, 60,000 patients would be treated every month and during the trial of 330 people, most of the patients were successfully treated within 4 days.

He said further research on the drug would continue and that the Ministry of Health would approve its use through a special high-speed process, while its preparation in Russia began in March.
He added that the drug, in pill form, would allow patients to spend less time in the hospital and reduce the time it takes for the virus to be transmitted to other people, especially for mild or moderately ill people. Is more efficient.
"Russian experts have made some changes to the drug to make it more effective for code 19, and we will share the details of these changes with others within two weeks," he said.

He said the Middle East and Latin American countries have expressed interest in purchasing the drug and it will be exported once its demand is met. Scientists' interest in FujiPir, a drug manufactured by Fumaji's Toma Chemical Company, grew when a study in China revealed the results in March.

Testing of the drug in China began in February and its clinical trial was approved on March 15, and officials say its effects on patients have been encouraging so far. During a study in Shenzhen in February, 320 patients with code 19 were given the drug, and the researchers found that it cleared the virus in an average of 4 days, compared to 11 days with other drugs.

More than 91% of patients using the drug also showed improvement in lung condition, compared to 63% in the other group. The researchers said that these data show that the drug cleans the virus faster, with fewer side effects discovered so far. Trials of the drug are also underway in Japan, and its use is likely to be approved soon.

The drug was developed by a company in the late 1990's and later bought by Fuji Film and is used against a type of influenza that is not affected by other drugs. The drug was used by Doctors Without Borders in 2014 to treat Ebola patients in Africa in collaboration with the World Health Organization.

Research in Guyana found that when the drug was administered to moderately ill people, the mortality rate dropped from 30% to 15%. Now the Japanese government expects the same benefits to be reaped against Code 19.
This drug is used in pill form and therefore may be more readily available than the remediator that is given in the form of an injection.

It should be noted that at present there is no cure for code 19 but its symptoms are treated with different drugs depending on their nature and the World Health Organization says that most patients recover.

Comments

Popular posts from this blog

Woman, the founder of human civilization

The world after the coronavirus and the reorganization of fossil capitalism

Corona virus: Where in the world is code 19 spreading and where is it declining?